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Background
This report is a summary of Device-associated (DA) Module data collected by hospitals 
participating in the National Healthcare Safety Network (NHSN) for events occurring from 
January through December 2012 and reported to the Centers for Disease Control and 
Prevention (CDC) by July 1, 2013. This report updates previously published DA Module 
data from NHSN and provides contemporary comparative rates.1 Figure 1 provides a brief 
summary of key findings from this report. This report complements other NHSN reports, 
including national and state-specific reports of standardized infection ratios (SIRs) for select 
healthcare-associated infections (HAIs).2, 3
NHSN data collection, reporting, and analysis are organized into four components: Patient 
Safety, Healthcare Personnel Safety, Biovigilance, and Long-term Care, and use 
standardized methods and definitions in accordance with specific module protocols.4,5,6,7 
Institutions may use modules singly or simultaneously, but once selected, they must be used 
for a minimum of one calendar month for the data to be included in CDC analyses. All 
infections are categorized using standard CDC definitions that include laboratory and 
clinical criteria.5–7 The DA Module within the Patient Safety Component may be used by 
facilities other than general acute care hospitals, including inpatient rehabilitation facilities 
(IRFs) and long term acute care hospitals (LTACHs). NHSN facilities contributing HAI 
surveillance data to this report did so voluntarily, in response to state mandatory reporting 
requirements or in compliance with the Centers for Medicare and Medicaid Services’ 
(CMS’s) Quality Reporting Programs.8,9 CDC aggregated these data into a single national 
database for 2012, consistent with the stated purposes of NHSN, which are to:
• Collect data from a sample of healthcare facilities in the United States to permit 
valid estimation of the magnitude of adverse events among patients and healthcare 
personnel.
The findings and conclusions of the report are those of the authors and do not necessarily represent the official position of the Centers 
for Disease Control and Prevention.
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• Collect data from a sample of healthcare facilities in the United States to permit 
valid estimation of the adherence to practices known to be associated with 
prevention of these adverse events.
• Analyze and report collected data to permit recognition of trends.
• Provide facilities with risk-adjusted metrics that can be used for inter-facility 
comparisons and local quality improvement activities.
• Assist facilities in developing surveillance and analysis methods that permit timely 
recognition of patient and healthcare worker safety problems and prompt 
intervention with appropriate measures.
• Conduct collaborative research studies with NHSN member facilities (e.g., describe 
the epidemiology of emerging healthcare-associated infection [HAI] and 
pathogens, assess the importance of potential risk factors, further characterize HAI 
pathogens and their mechanisms of resistance, and evaluate alternative surveillance 
and prevention strategies).
• Comply with legal requirements – including but not limited to state or federal laws, 
regulations, or other requirements – for mandatory reporting of healthcare facility-
specific adverse event, prevention practice adherence, and other public health data.
• Enable healthcare facilities to report HAI and prevention practice adherence data 
via NHSN to the U.S. Centers for Medicare and Medicaid Services (CMS) in 
fulfillment of CMS’s quality measurement reporting requirements for those data.
• Provide state departments of health with information that identifies the healthcare 
facilities in their state that participate in NHSN.
• Provide to state agencies, at their request, facility-specific, NHSN patient safety 
component and healthcare personnel safety component adverse event and 
prevention practice adherence data for surveillance, prevention, or mandatory 
public reporting.
Patient- and facility-specific data reported to CDC are kept confidential in accordance with 




For reporting to the DA Module, healthcare facility personnel responsible for infection 
prevention and patient safety may choose, with consideration of state mandates, federal 
reporting programs, and prevention initiatives, to collect data on central line-associated 
bloodstream infections (CLABSI), ventilator-associated pneumonias (VAP), or urinary 
catheter-associated urinary tract infections (CAUTI) that occur in patients staying in a 
patient care location such as a critical or intensive care unit (ICU), specialty care area, or 
inpatient ward. In NHSN, locations are further stratified according to patient population: 
adults, children, or neonates (in tables, pediatric and neonatal locations are so noted). In 
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neonatal intensive care unit (NICU) locations (level III or level II/III), infection 
preventionists (IPs) collect data on CLABSI or VAP that occur in patients in each of five 
birth-weight categories (≤750 g, 751–1000 g, 1001 – 1500 g, 1501 – 2500 g, and >2500 g); 
data on CAUTI are not collected as part of the NHSN protocols in any NICU location. 
Corresponding location-specific denominator data consisting of patient-days and specific 
device-days are also collected by IPs or other trained personnel.
In non-NICU locations, the device-days consist of the total number of central line-days, 
urinary catheter-days, or ventilator-days. For specialty care areas and oncology units, such 
as hematology/oncology and hematopoietic stem cell transplant locations, central line-days 
are split into those with only a permanent central line vs. those with temporary central lines 
(with or without a permanent central line). In NICU locations, the device-days consist of the 
total number of central line-days (inclusive of umbilical catheters), or ventilator-days for 
each birth-weight category.
Data Analysis Methods
Compared to the previous report, five new locations – gastrointestinal ward, pediatric 
orthopedic ward, inpatient hospice ward, solid tumor ward, and pediatric inpatient 
rehabilitation facility– had sufficient data to be included in this report.1
Locations were further stratified by facility type, unit bed size and/or major teaching status 
to determine if pooled mean rates, medians, and empirical distributions significantly differed 
between two groups for all DA infections; if differences were present, the strata were 
retained for reporting. Comparisons of pooled mean rates were performed using Poisson 
regression. These comparisons could be influenced by potential outlier rates from locations 
with disproportionately large denominators. Therefore, greater weight was given to the 
results of nonparametric tests comparing the medians for location shift and empirical 
distributions for assessing differences across the range of reported rates. These 
nonparametric comparisons by definition require no validity assumptions and provide test 
results that are not subject to the potential weighting influence of high or low rates with 
large denominators. Comparisons of the pooled mean, median and percentile distribution 
were made if there were at least 50 locations contributing to one or more strata and at least 
20 locations contributing to the percentile distribution in both strata.
Existing strata were retained for adult combined medical/surgical ICUs, medical ICUs, and 
surgical ICUs. The data for adult combined medical/surgical ICUs were split by medical 
school affiliation and unit bedsize, resulting in three groups: “major teaching,” “all others” 
with unit bedsize ≤15 beds, and “all others” with unit bedsize >15. The data for adult 
medical ICUs and adult surgical ICUs were split into two groups by teaching status. 
Hospitals self-identified their teaching hospital status through the annual NHSN facility 
survey. A major teaching hospital was defined as a hospital that has a program for medical 
students and post-graduate medical training. Locations within critical access hospitals 
(CAHs) were compared to their counterparts in all other acute care hospitals. The statistical 
evidence indicated that there was a significant difference in these strata and therefore, data 
from CAHs have been reported separate from all other location types. Adult hematology/
oncology locations were also evaluated to assess importance of status as an oncology 
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hospital, but differences were not significant and no new strata for this population were 
retained.
Device utilization (DU) was calculated as a ratio of device-days to patient-days for each 
location type. As such, the DU of a location is one measure of the use of invasive devices 
and constitutes an extrinsic risk factor for healthcare-associated infection.10 DU may also 
serve as a marker for severity of illness of patients (i.e. more severely ill patients are more 
likely to require an invasive device) which is another reflection of the intrinsic susceptibility 
to infection.
Data from at least 5 different reporting units of a given location type were used to determine 
pooled mean DA infection rates and DU ratios. Percentile distributions were determined if 
there were data from at least 20 different locations, excluding rates or DU ratios for 
locations that did not report at least 50 device-days or patient-days. Because of these 
requirements, the number of locations contributing data may vary among the tables.
Results
In 2012, 4,444 enrolled facilities reported at least one month of DA denominator data for 
some patient cohorts under surveillance. These 4,444 facilities were located in 53 states, 
territories, and the District of Columbia and were predominantly general acute care hospitals 
(Table 1); 27% of all facilities that reported data were smaller organizations of 50 beds or 
less, comprised mostly of acute care hospitals that were not identified as critical access. 
Among LTACHs and IRFs, 59% and 86%, respectively, were categorized as physically free-
standing from a hospital setting. Where data volume was sufficient for this report, we 
tabulated DA infection rates and DU ratios for January through December 2012 (Tables 3–
10). Data on the specific criteria used to report DA infections are provided in Tables 11–18.
Tables 3–6 update and augment previously published DA rates and DU ratios by type of 
non-NICU locations.1 Based on results of statistical comparisons, data from CAHs are 
reported separately from all other acute care hospitals. These data are further stratified into 
combined critical care units and combined non-critical care units.
Tables 7–10 update and augment the previously published DA rates and DU ratios by birth-
weight category for NICU locations.1 Beginning in January 2012, CLABSI data in NICU 
locations were no longer collected according to central line type (i.e., central line and 
umbilical catheter); therefore, CLABSI rates and DU ratios for NICUs are not stratified by 
line type in this report.
Tables 11–18 provide data on select attributes of the DA infections for each location. For 
example, Tables 11, 12, 15 and 16 show the frequency and percent distribution of the 
specific sites of CLABSI and the criteria used for identifying these infections. Note that for 
these tables, criteria 2 and 3, which involve common commensals only, have been 
combined.
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This report summarizes the HAI data reported to the DA module of NHSN during 
2012.Compared to the healthcare facility types for which HAI data were summarized in the 
last published report, in this report there is a slight increase in smaller hospitals, IRFs, and 
LTACHs.1 Based on the number of facilities reporting, overall contribution from all facility 
types to the device-associated module increased by 15% from the last report.1 This increase 
in reporting is largely attributable to healthcare facilities’ participation in CMS’s Quality 
Reporting Programs which require participants to use NHSN as the tool to report CLABSI 
data from all acute care hospital adult, pediatric, and neonatal ICUs (effective as of January 
2011)and all LTACH locations, as well as CAUTI data from all acute care hospital adult and 
pediatric ICUs, and all LTACH and IRF locations (effective as of January 2012).8,9 While 
this growth impacted the volume of reporting in these designated settings, there is also an 
indication of increased participation in ward locations for CLABSI and CAUTI surveillance.
Extensive analyses of the impact of facility type and medical school affiliation on all DA 
infection rates were performed for select locations. Medical school affiliation continues to 
be a significant factor for all three DA infection rates and/or percentile distributions in 
medical ICUs and surgical ICUs. All DA infection rate pooled means in this report continue 
to be higher in those locations stratified as major teaching compared to their non-major 
teaching counterparts. This suggests room for targeted prevention efforts in these settings 
that care for higher complexity patients. Additionally, medical school affiliation and bed 
size both continue to be significant factors in DA infection rates for medical/surgical ICUs. 
Note that while the CLABSI rates between unit bedsize strata in medical/surgical “all other” 
ICUs are equal (Table 3), the percentile distributions were shown to be significantly 
different as a result of nonparametric statistical tests. Therefore, this stratification by unit 
bedsize in “all other” medical/surgical ICUs was retained. Adult hematology/oncology 
locations were not further stratified by hospital type (i.e., oncology hospital vs. all other 
acute care hospitals) as the results of the statistical tests indicated that the differences in the 
strata were not statistically significant. In 2013, oncology and general acute care hospitals 
were provided with fourteen oncology-specific CDC locations with which to identify for 
device-associated infection surveillance. As the volume of these data become sufficient, 
future analyses will continue to assess any potential differences in this specialized 
population.
In 2012, facilities participating in NHSN were able to designate themselves as CAHs. This 
information allowed for the comparison of DA rates and DU ratios in these hospitals to all 
other hospitals. The results of the statistical tests indicated that DA rates and DU ratios in 
CAHs are significantly different from all other hospitals and therefore, CAHs are now able 
to compare themselves to pooled means generated from like-hospitals. This allows for more 
targeted prevention efforts in this unique setting.
In producing this report, there were several areas identified for which prevention activities 
and further investigation may be needed, both at the national and local levels. For example, 
the CLABSI pooled mean rate for LTACH critical care units is higher than most other 
critical care unit types (Table 3). Similarly, the CAUTI pooled mean rate for LTACH wards 
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is higher than CAUTI pooled mean rates in the majority of other ward-level locations (Table 
5). Further, when compared to the previous report, CAUTI rates have increased in every 
critical care unit type, with the exception of “Surgical critical care – all others” (Table 5).1 
Additional key findings from this report can be found in Figure 1.
Tables 11–18 were included to aid the reader in interpreting the DA infection rates data. One 
important use of data in these tables is to better understand the distribution of DA infections 
by type of reporting criterion nationally. For example, nearly 85% of the CLABSIs from 
adult and pediatric ICUs and inpatient wards were identified using criterion (1) which 
attributes the CLABSI to a recognized pathogen; however, for NICUs, only 70% used this 
criterion, resulting in a greater percentage of CLABSIs in this population that were 
identified with common commensals. Similarly, the specific type of ventilator-associated 
pneumonia (VAP) most frequently reported, regardless of location, was the clinical criterion 
(PNU1) which relies on the somewhat subjective interpretations of clinical findings.
As diverse types of facilities continue to participate in NHSN, either voluntarily or by 
mandate, the need for careful scrutiny of the data increases. NHSN will continue to assess 
how changing facility composition and changes in the proportion of data contributed by 
facility types impact the rates and their distributions so that the best possible risk-adjusted 
comparative data may be provided in future reports.
To improve the reliability of data reported to NHSN, several protocol changes were 
introduced in January 2013. The majority of these changes were with respect to timing and 
implementation of two-day rules to clarify infections that are healthcare-associated, 
association of device use to HAI, and attribution of HAI to an inpatient location after 
transfer or to a hospital after discharge. In addition, NHSN added criteria for mucosal barrier 
injury laboratory-confirmed bloodstream infections, which have not been removed or 
accounted for separately in this report. Finally, the VAP definition no longer applies to adult 
patients (i.e., ≥ 18 years of age) and this definition has been replaced by ventilator-
associated events (VAEs).11 We will carefully assess the potential impact of these changes 
on HAI incidence as these data are reported.
For those who do not report to NHSN but would like to use these data for comparison, the 
information must first be collected from your hospital in accordance with the methods 
described for NHSN.5–7 Refer to Appendices A and B for further instructions. Appendix A 
discusses the calculation of infection rates and DU ratios for the DA Module. Appendix B 
gives a step-by-step method for interpretation of percentiles of infection rates or DU ratios. 
Although a high rate or ratio (>90th percentile) does not necessarily define a problem, it 
does suggest an area for further investigation. Similarly, a low rate or ratio (<10th 
percentile) may be the result of inadequate infection detection.
Facilities should use the data in this report and their own data to guide local prevention 
strategies and other quality improvement efforts to reduce the occurrence of infections as 
much as possible. The data presented in this report can be used to prioritize prevention 
efforts in those patient care areas that are shown to have the highest incidence of DA 
infections and/or high device utilization. Facilities may also wish to set targets based on the 
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percentile distributions provided in this report in an effort to strive for lower rates and 
greater prevention success.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
NHSN facilities contributing data used in this report
Hospital type N (%)
Children's 70 (1.6)
Critical access 324 (7.3)
General, including acute, trauma, and teaching 3,200 (72.0)







Veterans' Affairs 12 (0.3)
Women's 6 (0.1)
Women's and Children's 9 (0.2)
Total 4,444
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